SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TGEN - Targeted Genetics Corporation
TGEN 8.230+0.9%Nov 7 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: James Reynolds who started this subject2/4/2004 11:06:25 PM
From: Mike McFarlandRead Replies (1) of 557
 
<public offering of approximately 10.9 million shares
of its common stock at a price of $2.35 per share to
institutional investors, for gross proceeds of
approximately $25.5 million>

This is one scrappy company, well done!

Up something like 10x from the 25cent low,
Tgen never dies--I'm a little sorry to have
given up on them last year. Does anybody on
SI still follow them closely? Are they down
to the HIV vaccine stuff or do they still
work on CF and their flavor of the AAV vector?

I've wondered if AAV might be useful for delivering
interfereing RNAs. I see a lot of buzz over RNAi
or siRNA or whatever the nomenclature. Maybe Tgen
will tap into that somehow...get something out of
all the work they have put into AAV. Let us not
forget that they went to some trouble to snag Genovo
a few years back and surely they got something for
the trouble.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News